BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33976130)

  • 1. FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer.
    Huang Y; Zhang HL; Li ZL; Du T; Chen YH; Wang Y; Ni HH; Zhang KM; Mai J; Hu BX; Huang JH; Zhou LH; Yang D; Peng XD; Feng GK; Tang J; Zhu XF; Deng R
    Nat Commun; 2021 May; 12(1):2672. PubMed ID: 33976130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian α-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans.
    Yang Q; Wang LX
    J Biol Chem; 2016 May; 291(21):11064-71. PubMed ID: 27008861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.
    Bastian K; Scott E; Elliott DJ; Munkley J
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate aglycone modification significantly expands the glycan substrate acceptability of α1,6-fucosyltransferase (FUT8).
    Zhang R; Yang Q; Boruah BM; Zong G; Li C; Chapla D; Yang JY; Moremen KW; Wang LX
    Biochem J; 2021 Apr; 478(8):1571-1583. PubMed ID: 33734311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of
    Yang Q; Zhang R; Cai H; Wang LX
    J Biol Chem; 2017 Sep; 292(36):14796-14803. PubMed ID: 28729420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
    Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
    Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.
    Liu Z; Meng X; Zhang Y; Sun J; Tang X; Zhang Z; Liu L; He Y
    Int J Oral Sci; 2024 Mar; 16(1):26. PubMed ID: 38548747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive domains and activity regulation of core fucosylation enzyme FUT8.
    Tomida S; Nagae M; Kizuka Y
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130561. PubMed ID: 38218458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy.
    Huang C; Li H; Feng Y; Li X; Zhang Z; Jiang C; Wang J; Yang C; Fu Y; Mu M; Zhao S; Wang Z; Kuang Y; Hou H; Wang Y; Guo W; Xu J; Yang H; Zhou L; Tong A; Guo G
    Theranostics; 2020; 10(23):10498-10512. PubMed ID: 32929362
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.
    Okagawa Y; Takada K; Arihara Y; Kikuchi S; Osuga T; Nakamura H; Kamihara Y; Hayasaka N; Usami M; Murase K; Miyanishi K; Kobune M; Kato J
    PLoS One; 2016; 11(12):e0168355. PubMed ID: 27977808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of glycosylation in triple negative breast cancer: a review.
    Chakraborty M; Kaur J; Gunjan ; Kathpalia M; Kaur N
    Glycoconj J; 2024 Apr; 41(2):79-91. PubMed ID: 38634956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling.
    Wang X; Gu J; Ihara H; Miyoshi E; Honke K; Taniguchi N
    J Biol Chem; 2006 Feb; 281(5):2572-7. PubMed ID: 16316986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate Preference and Interplay of Fucosyltransferase 8 and N-Acetylglucosaminyltransferases.
    Tseng TH; Lin TW; Chen CY; Chen CH; Lin JL; Hsu TL; Wong CH
    J Am Chem Soc; 2017 Jul; 139(28):9431-9434. PubMed ID: 28678517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
    Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
    Cancer Lett; 2018 Dec; 438():165-173. PubMed ID: 30227220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma.
    Tada K; Ohta M; Hidano S; Watanabe K; Hirashita T; Oshima Y; Fujnaga A; Nakanuma H; Masuda T; Endo Y; Takeuchi Y; Iwashita Y; Kobayashi T; Inomata M
    Surg Today; 2020 Jul; 50(7):767-777. PubMed ID: 31950256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core fucosylation of μ heavy chains regulates assembly and intracellular signaling of precursor B cell receptors.
    Li W; Liu Q; Pang Y; Jin J; Wang H; Cao H; Li Z; Wang X; Ma B; Chi Y; Wang R; Kondo A; Gu J; Taniguchi N
    J Biol Chem; 2012 Jan; 287(4):2500-8. PubMed ID: 22084235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation.
    Ng BG; Xu G; Chandy N; Steyermark J; Shinde DN; Radtke K; Raymond K; Lebrilla CB; AlAsmari A; Suchy SF; Powis Z; Faqeih EA; Berry SA; Kronn DF; Freeze HH
    Am J Hum Genet; 2018 Jan; 102(1):188-195. PubMed ID: 29304374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation.
    Tomida S; Takata M; Hirata T; Nagae M; Nakano M; Kizuka Y
    J Biol Chem; 2020 Jun; 295(23):7992-8004. PubMed ID: 32350116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 upregulates Fut8 expression by activating the Wnt/β-catenin pathway to enhance HCC cell proliferative and invasive ability.
    Zhang C; Wu Q; Huang H; Chen X; Huang T; Li W; Zhang J; Liu Y
    Cell Biol Int; 2020 Nov; 44(11):2202-2212. PubMed ID: 32710651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.